Literature DB >> 34761301

Th17/Treg cells regulated by interleukin 6 in the pathogenesis of chronic rhinosinusitis with nasal polyps.

Haiyang Li1, Yongle Wang1, Jianting Wang2.   

Abstract

PURPOSE: To be investigated whether Th17/Treg cells regulated by Interleukin-6 in the pathogenesis of chronic rhinosinusitis with nasal polyps.
METHODS: The distributions of Th17 and Treg cells in peripheral blood mononuclear cells (PBMCs) and tissues got from 46 CRSwNP patients and 14 controls were evaluated. Th17 and Treg cells and cells-related cytokines in serum were assessed in means of cytometric bead array (CBA) multiplex assays and enzyme-linked immunosorbent assays (ELISAs). Spleen cells were isolated from spleen of 20 normal BALB/c mice (male), isolated and purified with CD4 antibody immunomagnetic bead kit. CD4+ cells were divided into three groups, including TGF-β1, TGF-β1+ IL-6 and control (PBS). Treg and Th17 cells and cells related cytokines were detected by flow cytometry (FCM) after collecting spleen cells. The level of IL-10 and IL-17 in supernatant was measured by ELISA.
RESULTS: Th17/Treg ratio and the level of IL-6 in both ECRSwNP (P < 0.05) and non-ECRSwNP (P < 0.05) were significantly increased when compared with control group, these were consistent with the previous findings. Experiments in vitro suggested that the level of Th17 cells in IL-6+ TGF-β1 group was significantly increased than TGF-β1 group and control group (P < 0.05). The ratio of cells expressed RoRγt in IL-6+ TGF-β1 group was much higher than TGF-β1 group (P < 0.05).
CONCLUSION: IL-6 might regulate the function of Th17 and Treg cells and the Th17/Treg ratio and have a role in the pathogenesis of CRSwNP.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Interleukin 6; Nasal polyps; Sinusitis; Th17 cells; Treg cells

Mesh:

Substances:

Year:  2021        PMID: 34761301     DOI: 10.1007/s00405-021-07163-z

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  24 in total

1.  Predictive significance of tissue eosinophilia for nasal polyp recurrence in the Chinese population.

Authors:  Hongfei Lou; Yifan Meng; Yingshi Piao; Chengshuo Wang; Luo Zhang; Claus Bachert
Journal:  Am J Rhinol Allergy       Date:  2015-07-27       Impact factor: 2.467

2.  Cellular phenotyping of chronic rhinosinusitis with nasal polyps.

Authors:  Hongfei Lou; Yifan Meng; Yingshi Piao; Nan Zhang; Claus Bachert; Chengshuo Wang; Luo Zhang
Journal:  Rhinology       Date:  2016-06       Impact factor: 3.681

3.  Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper.

Authors:  Marek L Kowalski; Ioana Agache; Sevim Bavbek; Arzu Bakirtas; Miguel Blanca; Grażyna Bochenek; Matteo Bonini; Enrico Heffler; Ludger Klimek; Tanya M Laidlaw; Joaquim Mullol; Ewa Niżankowska-Mogilnicka; Hae-Sim Park; Marek Sanak; Mario Sanchez-Borges; Silvia Sanchez-Garcia; Glenis Scadding; Masami Taniguchi; Maria J Torres; Andrew A White; Aleksandra Wardzyńska
Journal:  Allergy       Date:  2018-10-02       Impact factor: 13.146

Review 4.  Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps.

Authors:  Enrico Heffler; Luca Malvezzi; Monica Boita; Luisa Brussino; Armando De Virgilio; Matteo Ferrando; Francesca Puggioni; Francesca Racca; Niccolò Stomeo; Giuseppe Spriano; Giorgio Walter Canonica
Journal:  Expert Rev Clin Immunol       Date:  2018-08-22       Impact factor: 4.473

5.  Peripheral blood and tissue T regulatory cells in chronic rhinosinusitis.

Authors:  Shilpy Sharma; So Watanabe; Anita Sivam; JiangHong Wang; Samantha J Neuwirth; Rosanne I Perez; Marcella De Tineo; Fuad M Baroody; Robert M Naclerio; Jayant M Pinto
Journal:  Am J Rhinol Allergy       Date:  2012 Sep-Oct       Impact factor: 2.467

6.  The impact of asthma on quality of life and symptoms in patients with chronic rhinosinusitis.

Authors:  Ana Penezić; Matej Paić; Tomislav Gregurić; Marko Velimir Grgić; Tomislav Baudoin; Livije Kalogjera
Journal:  Curr Med Res Opin       Date:  2020-04-23       Impact factor: 2.580

Review 7.  Eosinophilic chronic rhinosinusitis.

Authors:  Shigeharu Fujieda; Yoshimasa Imoto; Yukinori Kato; Takahiro Ninomiya; Takahiro Tokunaga; Toshiki Tsutsumiuchi; Kanano Yoshida; Masanori Kidoguchi; Tetsuji Takabayashi
Journal:  Allergol Int       Date:  2019-08-09       Impact factor: 5.836

8.  Mucosal eosinophilia and recurrence of nasal polyps - new classification of chronic rhinosinusitis.

Authors:  T Nakayama; M Yoshikawa; D Asaka; T Okushi; Y Matsuwaki; N Otori; T Hama; H Moriyama
Journal:  Rhinology       Date:  2011-10       Impact factor: 3.681

9.  Revision surgery rates in chronic rhinosinusitis with nasal polyps: meta-analysis of risk factors.

Authors:  Catherine A Loftus; Zachary M Soler; Sina Koochakzadeh; Vincent M Desiato; Frederick Yoo; Shaun A Nguyen; Rodney J Schlosser
Journal:  Int Forum Allergy Rhinol       Date:  2019-11-21       Impact factor: 3.858

10.  Long-term outcomes of different endoscopic sinus surgery in recurrent chronic rhinosinusitis with nasal polyps and asthma.

Authors:  L Zhang; Y Zhang; Y Gao; K Wang; H Lou; Y Meng; C Wang
Journal:  Rhinology       Date:  2020-04-01       Impact factor: 3.681

View more
  3 in total

1.  Activation of the hedgehog signaling pathway is associated with the promotion of cell proliferation and epithelial-mesenchymal transition in chronic rhinosinusitis with nasal polyps.

Authors:  Yankun Wang; Xiuwei Wang; Mulan Jin; Jun Lu
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-10-03       Impact factor: 3.236

Review 2.  Psoriasis and Systemic Inflammatory Disorders.

Authors:  Tomoko Tashiro; Yu Sawada
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208

Review 3.  Role and Function of Regulatory T Cell in Chronic Rhinosinusitis with Nasal Polyposis.

Authors:  Chenyang Lei; Juan Jiang; Yanyan Zhang; Gaoyun Xiong
Journal:  J Immunol Res       Date:  2022-03-26       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.